AKT1 and neoplasm: Analysis of the differentially expressed miRs revealed that while the oncomirs, miR-21, miR-29b, miR-142-3p, and miR-203 targeted the p53 signaling pathway, the tumor suppressor miRs, let-7a, let-7d, let-7f, miR-16, and/or miR-143 targeted the PI3K/Akt signaling pathway.